Suraksha Diagnostic has launched one of the largest and a state-ofthe-art Genomics Lab in Eastern India. This Lab is equipped with cytogenetics, microarray technology, sanger sequencing, multiple next-generation sequencers (NGS). Together, these technologies enable the full spectrum of advanced genetic testing, offering predictive, preventive, and personalized care.
The company’s Genomics Lab enables the detection of chromosomal abnormalities like Down syndrome, Edwards syndrome, and Patau syndrome, as well as sex chromosome aneuploidies and microdeletions. These insights help expecting parents make informed decisions, supported by expert genetic counseling.
Suraksha Diagnostic is primarily engaged in the business of running diagnostic centres for carrying out various pathological and radiological services.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7699.05 |
| Max Healthcare Inst | 1006.90 |
| Narayana Hrudayalay | 1825.55 |
| Aster DM Healthcare | 688.30 |
| Global Health | 1089.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: